☆ 4.7 Article

Liver-Gut-Interaction: Role of Microbiome Transplantation in the Future Treatment of Metabolic Disease

JOURNAL OF PERSONALIZED MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation

Lili Su et al.

Summary: Type 2 diabetes is linked to gut microbiota dysbiosis, and dietary interventions and fecal microbiota transplantation show potential in improving the health of patients with type 2 diabetes. FMT has a quicker impact on the gut microbiota compared to diet. Beneficial bacteria such as Bifidobacterium increase and are negatively correlated with blood glucose, blood pressure, blood lipid, and BMI, while sulfate-reducing bacteria, Bilophila, and Desulfovibrio decrease and are positively correlated with blood glucose indices.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial

Siew C. Ng et al.

Summary: Repeated FMTs enhance microbiota engraftment in obese patients with T2DM, leading to more favorable changes in recipients' microbiota and improvement in lipid profile and liver stiffness when combined with lifestyle intervention.

GUT (2022)

Add to Collection

Review Gastroenterology & Hepatology

Adverse events of intestinal microbiota transplantation in randomized controlled trials: a systematic review and meta-analysis

Chong Chen et al.

Summary: This systematic review and meta-analysis evaluated the safety of intestinal microbiota transplantation (IMT). The results showed no significant increase in the incidence of serious adverse events and common adverse events with IMT. However, the delivery methods may affect the occurrence of common adverse events. To improve the safety of IMT, a thorough evaluation of patients' conditions and appropriate transplantation methods should be considered.

GUT PATHOGENS (2022)

Add to Collection

Article Immunology

Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients

Dafa Ding et al.

Summary: This study found that fecal microbiota transplantation (FMT) therapy can improve symptoms and metabolic parameters in patients with type 2 diabetes mellitus (T2DM). Out of 17 patients, 11 showed significant improvement. Additionally, the presence of certain microbial species can predict the clinical response to FMT treatment.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Add to Collection

Article Immunology

Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial

Lanfeng Xue et al.

Summary: Fecal microbiota transplantation (FMT) can attenuate fat accumulation in patients with non-alcoholic fatty liver disease (NAFLD) by improving gut microbiota dysbiosis. Significant differences in clinical features and gut microbiota were observed between lean and obese NAFLD patients, with FMT showing better effects in lean NAFLD patients.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases

Yun Wang et al.

Summary: This review provides a comprehensive overview of the clinical applications of fecal microbiota transplantation (FMT) from 2011 to 2021. The study examines the clinical benefits, processing methodology, usage strategies, and global regulations of FMT. The findings suggest that while further controlled trials are needed, FMT shows promising potential for treating dysbiosis-related diseases in the gut or beyond.

CHINESE MEDICAL JOURNAL (2022)

Add to Collection

Article Gastroenterology & Hepatology

Bowel cancer screening workforce survey: developing the endoscopy workforce for 2025 and beyond

Srivathsan Ravindran et al.

Summary: The survey identified a potential serious shortage of screening colonoscopists in the next 5-10 years due to an ageing workforce and job plan pressures of aspirant BCS colonoscopists. The survey outlined potential mitigations including reviewing job plans, improving workforce resources, and supporting accreditation and training.

FRONTLINE GASTROENTEROLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain

Ehud Rinott et al.

Summary: This study evaluated the efficacy and safety of diet-modulated autologous fecal microbiota transplantation (aFMT) for treatment of weight regain after the weight-loss phase. The results showed that in the green-Mediterranean diet group, aFMT significantly reduced weight regain and waist circumference gain, improved insulin rebound, and induced significant changes in gut microbiome composition. The green-Mediterranean diet also preserved weight-loss-associated specific bacteria and microbial metabolic pathways after the aFMT procedure.

GASTROENTEROLOGY (2021)

Add to Collection

Article Oncology

Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study

Nicolien C. de Clercq et al.

Summary: A study on fecal microbiota transplantation in cachectic patients with gastroesophageal cancer showed that allogenic FMT did not improve cachexia, but led to better disease control rate, overall survival, and progression-free survival. Patients in the allogenic group also experienced significant changes in fecal microbiota composition after FMT. This suggests a potential benefit of FMT in improving treatment response and survival in advanced gastroesophageal cancer patients.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Medicine, General & Internal

Autologous fecal microbiota transplantation can retain the metabolic achievements of dietary interventions

Ehud Rinott et al.

Summary: The study found that during autologous fecal microbiota transplantation treatment, patients were able to maintain metabolic benefits achieved during the weight loss phase, including stability in weight, blood sugar, and blood lipids.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Article Microbiology

Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

Brooke C. Wilson et al.

Summary: The study showed that multi-donor FMT can significantly alter the structure and function of the gut microbiome, with evidence for the existence of super-donors whose microbiomes are highly effective at engrafting in recipient gut. However, despite efforts to standardize FMT dose and origin, there was high variability in strain engraftment among FMT recipients.

MICROBIOME (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial

Valentin Mocanu et al.

Summary: The study demonstrated that a single-dose oral FMT combined with daily low-fermentable fiber supplementation significantly improved insulin sensitivity in patients with severe obesity and metabolic syndrome.

NATURE MEDICINE (2021)

Add to Collection

Article Gastroenterology & Hepatology

Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome

Eduard W. J. van der Vossen et al.

Summary: Accumulating evidence suggests that allogenic fecal microbial transplant (FMT) leads to greater shifts in gut microbiota compared to autologous FMT, potentially modulating the plasma metabolome and epigenome. Specifically, the introduction of Prevotella ASVs has been directly correlated with DNA methylation of AFAP1, a gene involved in mitochondrial function, insulin sensitivity, and peripheral insulin resistance.

GUT MICROBES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome

Pilar Manrique et al.

Summary: Metabolic Syndrome (MetS) poses a global public health concern, increasing the risk of cardiovascular diseases and type 2 diabetes. Fecal microbiota transplantation (FMT) for MetS can impact the gut bacteriophage community, with better clinical outcomes associated with similarity to healthy donors. Identified bacteriophage groups may help explain differences in treatment response.

GUT MICROBES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients

Jessica R. Allegretti et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial

Laura Craven et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial

Elaine W. Yu et al.

PLOS MEDICINE (2020)

Add to Collection

Article Endocrinology & Metabolism

Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome

Annick Hartstra et al.

MOLECULAR METABOLISM (2020)

Add to Collection

Article Medicine, General & Internal

Effects of Fecal Microbiome Transfer in Adolescents With Obesity The Gut Bugs Randomized Controlled Trial

Karen S. W. Leong et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Review Medicine, General & Internal

Fecal microbiota transplantation: Review and update

Jiunn-Wei Wang et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)

Add to Collection

Review Endocrinology & Metabolism

Obesity: global epidemiology and pathogenesis

Matthias Blueher

NATURE REVIEWS ENDOCRINOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

T cell-mediated regulation of the microbiota protects against obesity

Charisse Petersen et al.

SCIENCE (2019)

Add to Collection

Review Nutrition & Dietetics

Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review

Zhengxiao Zhang et al.

NUTRIENTS (2019)

Add to Collection

Review Immunology

The Super-Donor Phenomenon in Fecal Microbiota Transplantation

Brooke C. Wilson et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Add to Collection

Letter Gastroenterology & Hepatology

Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for Clostridium difficile Infection

Monika Fischer et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection

Christoph A. Thaiss et al.

SCIENCE (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome

Loek P. Smits et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)

Add to Collection

Article Gastroenterology & Hepatology

Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection

Stephan J. Ott et al.

GASTROENTEROLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

European consensus conference on faecal microbiota transplantation in clinical practice

Giovanni Cammarota et al.

GUT (2017)

Add to Collection

Review Microbiology

The Human Microbiome and Obesity: Moving beyond Associations

Padma Maruvada et al.

CELL HOST & MICROBE (2017)

Add to Collection

Article Multidisciplinary Sciences

Durable coexistence of donor and recipient strains after fecal microbiota transplantation

Simone S. Li et al.

SCIENCE (2016)

Add to Collection

Article Immunology

Weight Gain After Fecal Microbiota Transplantation

Neha Alang et al.

OPEN FORUM INFECTIOUS DISEASES (2015)

Add to Collection

Article Multidisciplinary Sciences

Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice

Vanessa K. Ridaura et al.

SCIENCE (2013)

Add to Collection

Article Gastroenterology & Hepatology

Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome

Anne Vrieze et al.

GASTROENTEROLOGY (2012)

Add to Collection

Article Endocrinology & Metabolism

Metabolic endotoxemia initiates obesity and insulin resistance

Patrice D. Cani et al.

DIABETES (2007)

Add to Collection

Article Multidisciplinary Sciences

An obesity-associated gut microbiome with increased capacity for energy harvest

Peter J. Turnbaugh et al.

NATURE (2006)

Add to Collection

Article Multidisciplinary Sciences

Obesity alters gut microbial ecology

RE Ley et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Add to Collection

Article Multidisciplinary Sciences

The gut microbiota as an environmental factor that regulates fat storage

F Bäckhed et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.